Rafael Barcena

Summary

Country: Spain

Publications

  1. doi request reprint Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period
    Rafael Barcena
    Service of Liver Gastroenterology, Spain
    J Hepatol 58:421-6. 2013
  2. pmc Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers
    Rafael Barcena
    Department of Gastroenterology, Hospital Ramon y Cajal, Facultad de Medicina, Universidad de Alcala, Ctra Colmenar Km 9 1, 28034 Madrid, Spain
    World J Gastroenterol 12:2070-4. 2006
  3. doi request reprint Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome
    Rafael Barcena
    Liver Gastroenterology, Hospital Ramon y Cajal, Madrid 28034, Spain
    Clin Transplant 24:366-74. 2010
  4. ncbi request reprint The magnitude of week 4 HCV RNA decay on pegylated interferon/ribavirin accurately predicts virological failure in patients with genotype 1
    Rafael Barcena
    Service of Gastroenterology, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid, Spain
    Antivir Ther 12:401-6. 2007
  5. ncbi request reprint Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?
    Rafael Barcena
    Services of Liver Gastroenterology, Hospital Ramon y Cajal, Madrid, Spain
    Clin Transplant 20:517-23. 2006
  6. ncbi request reprint Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?
    Rafael Barcena
    Hepato Gastroenterology Service, Ramon y Cajal Hospital, Madrid, Spain
    Am J Transplant 5:2796-8. 2005
  7. ncbi request reprint Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine
    R Barcena Marugan
    Department of Gastroenterology, Hospital Ramon y Cajal, Facultad de Medicina, Universidad de Alcala, Madrid, Spain
    Transplant Proc 35:1841-3. 2003
  8. ncbi request reprint Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Leonor Moreno
    Department of Infectious Diseases, Hospital Ramon y Cajal, Madrid, Spain
    AIDS 18:67-73. 2004
  9. ncbi request reprint HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin
    Ana Moreno
    Service of Infectious Diseases, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid, Spain
    J Hepatol 43:783-90. 2005
  10. ncbi request reprint Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization
    José R Foruny
    Department of Hepatology and Gastroenterology, Hospital Ramon y Cajal, Madrid, Spain
    Eur J Gastroenterol Hepatol 17:1157-64. 2005

Collaborators

Detail Information

Publications22

  1. doi request reprint Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period
    Rafael Barcena
    Service of Liver Gastroenterology, Spain
    J Hepatol 58:421-6. 2013
    ..Short-term intravenous silibinin monotherapy is safe and shows a potent in vivo anti-HCV effect. We aimed at evaluating the safety and antiviral effect of prolonged intravenous silibinin, started immediately before liver transplantation...
  2. pmc Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers
    Rafael Barcena
    Department of Gastroenterology, Hospital Ramon y Cajal, Facultad de Medicina, Universidad de Alcala, Ctra Colmenar Km 9 1, 28034 Madrid, Spain
    World J Gastroenterol 12:2070-4. 2006
    ..To analyze whether the presence of anti-HBs in liver transplant recipients is effective in preventing HBV infection...
  3. doi request reprint Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome
    Rafael Barcena
    Liver Gastroenterology, Hospital Ramon y Cajal, Madrid 28034, Spain
    Clin Transplant 24:366-74. 2010
    ..There is limited information on the long-term outcome in liver transplant (LT) subjects undergoing partial splenic embolization (PSE) prior to full dose pegylated interferon/ribavirin (peg-IFN/RBV)...
  4. ncbi request reprint The magnitude of week 4 HCV RNA decay on pegylated interferon/ribavirin accurately predicts virological failure in patients with genotype 1
    Rafael Barcena
    Service of Gastroenterology, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid, Spain
    Antivir Ther 12:401-6. 2007
    ..Current stopping rules during pegylated interferon (peg-IFN)/ribavirin (RBV) treatment rely on week 12 HCV RNA response, but earlier identification of non-responders offers clinical and economic advantages...
  5. ncbi request reprint Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?
    Rafael Barcena
    Services of Liver Gastroenterology, Hospital Ramon y Cajal, Madrid, Spain
    Clin Transplant 20:517-23. 2006
    ..To describe the functional effect of partial splenic embolization (PSE) in liver-transplanted (LT) patients with hypersplenism and hepatitis C virus (HCV) recurrence...
  6. ncbi request reprint Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?
    Rafael Barcena
    Hepato Gastroenterology Service, Ramon y Cajal Hospital, Madrid, Spain
    Am J Transplant 5:2796-8. 2005
    ..In conclusion, active extrapulmonary tuberculosis should perhaps be considered for liver transplantation when FHF develops due to anti-tuberculous drugs...
  7. ncbi request reprint Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine
    R Barcena Marugan
    Department of Gastroenterology, Hospital Ramon y Cajal, Facultad de Medicina, Universidad de Alcala, Madrid, Spain
    Transplant Proc 35:1841-3. 2003
    ..There were no toxic side effects due to adefovir treatment. The data confirm that adefovir treatment has efficacy against HBV lamivudine-resistant forms...
  8. ncbi request reprint Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Leonor Moreno
    Department of Infectious Diseases, Hospital Ramon y Cajal, Madrid, Spain
    AIDS 18:67-73. 2004
    ..We evaluated the safety and efficacy of Pegylated interferon alpha2b (Peg-IFN) and a fixed dose of ribavirin in the treatment of chronic hepatitis C in HIV coinfection...
  9. ncbi request reprint HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin
    Ana Moreno
    Service of Infectious Diseases, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid, Spain
    J Hepatol 43:783-90. 2005
    ..Differences in HCV-RNA clearance during therapy might explain the lower efficacy of peg-IFN/RBV in HIV/HCV-coinfection. There are limited data on HCV-RNA clearance and treatment outcomes in liver transplanted (LT) patients...
  10. ncbi request reprint Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization
    José R Foruny
    Department of Hepatology and Gastroenterology, Hospital Ramon y Cajal, Madrid, Spain
    Eur J Gastroenterol Hepatol 17:1157-64. 2005
    ..Thrombocytopenia precludes the use of pegylated interferon (peg-IFN) and ribavirin in cirrhotic patients with hepatitis C virus (HCV). We aimed to evaluate the role of PSE as a procedure allowing combined HCV therapy in this setting...
  11. ncbi request reprint Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin
    Ana Moreno
    Infectious Diseases, Hospital Ramon y Cajal, Madrid, Spain
    Antivir Ther 9:1027-30. 2004
    ..Although preliminary, these results suggest the potential role of PSE in HIV/HCV-cirrhotic subjects with hypersplenism as a procedure to allow the use of combined PEG-IFN and RBV...
  12. ncbi request reprint Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature
    Ana Moreno
    Service of Infectious Diseases, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid 28034, Spain
    Hum Pathol 37:1344-9. 2006
    ..Specific treatment with pegylated interferon and ribavirin can lead to histological resolution and biochemical improvement, even in the absence of HCV-RNA clearance...
  13. doi request reprint Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response
    Conrado M Fernández-Rodríguez
    Hospital Universitario Fundacion Alcorcon, Madrid, Spain
    Am J Gastroenterol 105:2164-72; quiz 2173. 2010
    ..Patients with hepatitis C virus (HCV) cirrhosis are difficult to treat and have a high risk of liver decompensation or hepatocellular carcinoma. We sought to identify factors that could predict treatment response...
  14. ncbi request reprint Liver transplantation in HIV-infected recipients
    Santiago Moreno
    Department of Infectious Diseases, Liver Transplant Unit, Hospital Ramon y Cajal, Universidad de Alcala de Henares, 28034 Madrid, Spain
    Liver Transpl 11:76-81. 2005
    ..If indicated, an antiretroviral regimen consisting of 3 nucleosides could be used to avoid interactions with immunosuppressive drugs...
  15. doi request reprint Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia
    Ana Moreno
    Infectious Diseases Service, Hospital Ramon y Cajal, Madrid, Spain
    Liver Transpl 17:331-3. 2011
    ....
  16. ncbi request reprint Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients
    Jesus Fortun
    Infectious Disease Department and Liver Transplant Group, Hospital Ramon y Cajal, Crtra Colmenar Km 9 1, Madrid 28034, Spain
    J Antimicrob Chemother 52:813-9. 2003
    ..Invasive fungal infections (IFI) are associated with high mortality in liver transplant recipients. Prevention remains an elusive goal, especially for IFI caused by moulds...
  17. ncbi request reprint Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C
    Javier Moreno
    Department of Gastroenterology, Hospital Ramony Cajal, Ctra Colmenar, Km 9 1, 28034 Madrid, Spain
    World J Gastroenterol 10:143-6. 2004
    ..PEG-IFN plus ribavirin have been useful in the treatment of chronic hepatitis C infection. This study investigated the responses of TT virus (TTV) and hepatitis C virus (HCV) to PEG-IFN plus ribavirin therapy...
  18. ncbi request reprint High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin
    Ana Moreno
    Infectious Diseases, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid, Spain
    Antivir Ther 9:133-8. 2004
    ..Nucleoside analogues may induce mitochondrial toxicity, particularly didanosine. Ribavirin increases didanosine exposure, which might be clinically relevant when coadministered in HIV/HCV-coinfected patients...
  19. doi request reprint False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients
    Jesus Fortun
    Department of Infectious Diseases, Hospital Ramon y Cajal, Madrid, Spain
    Transplantation 87:256-60. 2009
    ..Aspergillus galactomannan (GM) antigenemia is an early marker of invasive aspergillosis (IA), but may yield false-positive results. A prospective study, testing GM periodically in serum samples of liver transplant recipients, was performed...
  20. ncbi request reprint Risk factors for invasive aspergillosis in liver transplant recipients
    Jesus Fortun
    Infectious Diseases Department and Liver Transplant Unit, Ramon y Cajal Hospital, Alcala de Henares University, Madrid, Spain
    Liver Transpl 8:1065-70. 2002
    ..Cytomegalovirus infection and increased immunosuppression favor invasive aspergillosis during the late posttransplantation period. Aspergillus antigenemia seems to be a good predictor of invasive aspergillosis...
  21. ncbi request reprint [Acute hepatitis E in Madrid: description of 18 cases]
    Maria Luisa Mateos
    Servicio de Microbiología Hospital Ramón y Cajal Madrid España
    Gastroenterol Hepatol 29:397-400. 2006
    ..However, in the last few years, several sporadic autochthonous hepatitis E cases have been reported in Europe and no risk factors, such as visiting to endemic areas, could be found in these patients...
  22. doi request reprint Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis
    José L Calleja
    Department of Gastroenterology and Hepatology, University Hospital Puerta de Hierro Majadahonda, IDIPHIM and CIBEREHD, Madrid, Spain
    Liver Int 35:90-100. 2015
    ..The addition of protease inhibitors (PIs) changed the hepatitis C virus (HCV) treatment standards and improved sustained viral response (SVR) rates in patients with genotype 1 HCV infection...